News & Events - Angiodynamics
WEB2 days ago · Stay up to date on industry news, and company events and updates from AngioDynamics, global provider of disruptive and innovative medical products.
Angiodynamics - Global Leader in Vascular & Oncology Medical ...
WEBAngioDynamics focuses on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients worldwide.
AngioDynamics Receives FDA Breakthrough Device Designation …
WEBAug 15, 2023 · The accelerated pathway expedites assessment and review processes of the AngioVac System and allows for more interactive and timely communication with the FDA, efficient and flexible clinical study design, FDA review team support, Agency senior management engagement and priority review.
AngioDynamics Announces Sale of PICC and Midline Product …
WEBAngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million. February 15, 2024. PDF Version. Portfolio optimization enhances strategic focus and follows initiative to restructure manufacturing footprint.
Experience Our Global Presence | AngioDynamics International
WEBAngioDynamics International. Our international team brings leading oncology solutions and restorative flow technologies to customers and patients across the globe and enhances service delivery for our customers. Meet Your Team.
AngioDynamics Medical Technologies and Devices | Product …
WEBAngioDynamics’ portfolio of disruptive and innovative medical products provides physicians with tools to elevate the standard of care for patients in the diagnosis and treatment of cardiovascular and oncologic diseases.
AngioDynamics Reports Fiscal 2023 First Quarter Financial Results ...
WEBOct 6, 2022 · Fiscal Year 2023 First Quarter Highlights. Net sales of $81.5 million increased 5.9% compared to the prior-year quarter. Med Tech net sales of $22.8 million increased 29.6%. Med Device net sales of $58.7 million decreased 1.1%. Gross margin of 51.9% declined 20 basis points year over year.
AngioDynamics Announces Settlement of All Patent Litigation with …
WEBApr 1, 2024 · Under the terms of the settlement, BD will grant a license to AngioDynamics under certain of BD’s port patents and AngioDynamics will grant BD a license under certain of AngioDynamics’ catheter patents.
Announcements Archives - Angiodynamics
WEBFeb 13, 2024 · News & Events – The latest announcements and events from AngioDynamics Leadership – Meet the AngioDynamics leadership team Our Dynamic People – Meet our people who make a difference
AngioDynamics Announces First Patient Enrolled in APEX-AV …
WEBOct 31, 2022 · AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F18⁸⁵ PE System in Treatment of Pulmonary Embolism. AngioDynamics, The PERT Consortium™ and Viz.ai partner on APEX Study to facilitate future enrollment to bring innovative treatment to patients with PE.